We are live on
!
Find out more
DCM
DAFNA Capital Management Portfolio holdings
AUM
$440M
1-Year Est. Return
109.12%
This Fund
S&P 500
This Quarter
Est. Return
+42.82%
1 Year Est. Return
+109.12%
3 Year Est. Return
+239.59%
5 Year Est. Return
+227.89%
10 Year Est. Return
+3,611.91%
AUM
$417M
AUM Growth
+$95.9M
(+30%)
Cap. Flow
-$11.1M
Cap. Flow
% of AUM
-2.67%
Top 10 Holdings %
Top 10 Hldgs %
49.63%
Holding
82
New
7
Increased
14
Reduced
24
Closed
6
Top Buys
| 1 |
SAGE
Sage Therapeutics
SAGE
|
+$4.86M |
| 2 |
Syndax Pharmaceuticals
SNDX
|
+$4.37M |
| 3 |
Biohaven
BHVN
|
+$4.16M |
| 4 |
SLRN
ACELYRIN
SLRN
|
+$3.11M |
| 5 |
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
|
+$2.58M |
Top Sells
| 1 |
BPMC
Blueprint Medicines
BPMC
|
+$8.98M |
| 2 |
State Street SPDR S&P Biotech ETF
XBI
|
+$6.02M |
| 3 |
Nurix Therapeutics
NRIX
|
+$4.38M |
| 4 |
Cytokinetics
CYTK
|
+$2.88M |
| 5 |
AUTL
Autolus Therapeutics
AUTL
|
+$2.81M |
Sector Composition
| 1 | Healthcare | 85.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
State Street SPDR S&P Biotech ETF
XBI
$10.6B
| $43.2M | 10.36% |
484,000
-81,000
| -14% | -$6.02M |
|
|
2
Cytokinetics
CYTK
$11.2B
| $33.4M | 8% |
400,000
-79,538
| -17% | -$2.88M |
|
3
Stereotaxis
STXS
$161M
| $23.9M | 5.74% |
13,680,554
| – | – |
|
4
IDEAYA Biosciences
IDYA
$3.55B
| $18.4M | 4.4% |
516,341
+16,521
| +3% | +$493K |
|
|
5
Syndax Pharmaceuticals
SNDX
$2.08B
| $16M | 3.85% |
742,574
+284,201
| +62% | +$4.37M |
|
6
Ascendis Pharma A/S
ASND
$17.5B
| $15.6M | 3.73% |
123,472
-12,740
| -9% | -$1.27M |
|
|
KRTX
7
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $15.2M | 3.65% |
48,145
-4,728
| -9% | -$919K |
|
8
Revolution Medicines
RVMD
$39.3B
| $14.7M | 3.52% |
511,894
+38,500
| +8% | +$925K |
|
9
iShares Biotechnology ETF
IBB
$9.23B
| $13.9M | 3.34% |
102,500
| – | – |
|
10
Xenon Pharmaceuticals
XENE
$6.55B
| $12.7M | 3.05% |
276,739
-3,799
| -1% | -$134K |
|
|
MRUS
11
DELISTED
Merus
MRUS
| $12.5M | 3% |
454,870
-30,000
| -6% | -$701K |
|
|
BPMC
12
DELISTED
Blueprint Medicines
BPMC
| $10.2M | 2.45% |
110,863
-138,658
| -56% | -$8.98M |
|
|
DAWN
13
DELISTED
Day One Biopharmaceuticals
DAWN
| $10M | 2.4% |
686,463
+100,000
| +17% | +$1.21M |
|
14
Neurocrine Biosciences
NBIX
$17.2B
| $9.57M | 2.29% |
72,615
-1,000
| -1% | -$115K |
|
15
DexCom
DXCM
$28.4B
| $8.38M | 2.01% |
67,552
| – | – |
|
|
KALV
16
DELISTED
KalVista Pharmaceuticals
KALV
| $7.36M | 1.76% |
601,032
-4,500
| -0.7% | -$40.9K |
|
|
17
Biohaven
BHVN
$2.25B
| $7.22M | 1.73% |
168,772
+133,772
| +382% | +$4.16M |
|
18
Kura Oncology
KURA
$1B
| $7.08M | 1.7% |
492,684
-58,100
| -11% | -$571K |
|
|
MORF
19
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $6.69M | 1.6% |
231,748
| – | – |
|
20
Tandem Diabetes Care
TNDM
$1.07B
| $6.53M | 1.56% |
220,708
| – | – |
|
21
Axogen
AXGN
$2.05B
| $6.39M | 1.53% |
935,894
| – | – |
|
|
TSVT
22
DELISTED
2seventy bio
TSVT
| $6.18M | 1.48% |
1,447,465
| – | – |
|
|
IMGN
23
DELISTED
Immunogen Inc
IMGN
| $5.74M | 1.38% |
193,661
+110,661
| +133% | +$2.2M |
|
|
SAGE
24
DELISTED
Sage Therapeutics
SAGE
| $5.31M | 1.27% |
+245,000
| New | +$4.86M |
|
|
LKFT
25
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.94B
| $5.29M | 1.27% |
130,175
+70,000
| +116% | +$2.58M |
|
Similar funds
FGWP
STCG
SCP
CAAM
AWM
HCM
CPW
DWML